drug

BB-101

updated 3mo ago

by Blue Blood Biotech Corp

community read0 votes

🐶 often sniffed alongside

top 3

all catalysts(2)

constraining patent expiry europe · 1

Apr 26, 2026

constraining patent expiry europe

4mo ago

Blue Blood Biotech Corp — BB-101 (Constraining Patent Expiry (Europe))

patent expiry · 1

Blue Blood Biotech Corp — BB-101 (Constraining Patent Expiry (Japan))

BB-101

→

Trials studying BB-101

phase1BB-101 for Treatment of Diabetic Lower Leg and Foot Ulcerscompletedn=14
phase2BB-101 for the Treatment of Diabetic Lower Leg and Foot Ulcersrecruitingn=96

News(0)

no news has mentioned this drug yet

Data sources

ClinicalTrials.gov

last refreshed 7m ago

Found something off?

comments(0)

5-min edit window · permanent after that

no comments yet — first sniff?

drug

save

BB-101

updated 3mo ago

by Blue Blood Biotech Corp

community read0 votes

🐶 often sniffed alongside

top 3

all catalysts(2)

constraining patent expiry europe · 1

Apr 26, 2026

constraining patent expiry europe

4mo ago

Blue Blood Biotech Corp — BB-101 (Constraining Patent Expiry (Europe))

patent expiry · 1

Blue Blood Biotech Corp — BB-101 (Constraining Patent Expiry (Japan))

BB-101

→

Trials studying BB-101

phase1BB-101 for Treatment of Diabetic Lower Leg and Foot Ulcerscompletedn=14
phase2BB-101 for the Treatment of Diabetic Lower Leg and Foot Ulcersrecruitingn=96

News(0)

no news has mentioned this drug yet

Data sources

ClinicalTrials.gov

last refreshed 7m ago

Found something off?

comments(0)

5-min edit window · permanent after that

no comments yet — first sniff?

BB-101

🐶 often sniffed alongside

all catalysts(2)

Trials studying BB-101

News(0)

Report a data issue

comments(0)

BB-101

🐶 often sniffed alongside

all catalysts(2)

Trials studying BB-101

News(0)

Report a data issue

comments(0)